In what has now become a common mash-up of celebrity influence and pharmaceutical marketing, a recent direct-to-consumer (“DTC”) television advertisement ( “TV Ad”) came under fire from the Food and Drug Administration’s (“FDA”) Office of Prescription Drug Promotion (“OPDP” or “agency”) in the agency’s fourth Untitled Letter of the year. With only three months... READ MORE
From an Instagram Post to a Television Commercial, OPDP Issues Its Fourth Untitled Letter of 2024
Posted on October 16, 2024 in Health Law News
Published by: Hall Render